Data updated: Mar 10, 2026
SODIUM PENTOBARBITAL
PENTOBARBITAL SODIUM
Approved 1973-08-31
7
Indications
--
Phase 3 Trials
52
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1973-08-31
- Routes
- ORAL, INJECTION
- Dosage Forms
- TABLET, CAPSULE, INJECTABLE
Companies
NEXGEN PHARMA INC EVERYLIFE IVAX SUB TEVA PHARMS PARKE DAVIS PERRIGO Pfizer VALEANT PHARM INTL ELKINS SINN HALSEY WATSON LABS ANABOLIC PUREPAC PHARM
Active Ingredient: PENTOBARBITAL SODIUM
Website: ↗
SODIUM PENTOBARBITAL Approval History
Loading approval history...
What SODIUM PENTOBARBITAL Treats
7 FDA approvalsOriginally approved for its first indication in 1973 . Covers 7 distinct patient populations.
- Other (7)
Other
(7 approvals)- • Approved indication (Aug 1973)
- • Approved indication (Dec 1973)
- • Approved indication (Feb 1974)
- • Approved indication (Jun 1974)
- • Approved indication (Sep 1974)
- • Approved indication (Jan 1977)
- • Approved indication (Dec 1977)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
SODIUM PENTOBARBITAL FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.